← ANALYSTS · TIPRANKS
Daina Graybosch · Leerink Partners
Hits
39%
156 of 400 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
−7.8%
Over a year after the rating, TipRanks’ measure
Our companies rated now
9
Buy / hold / sell: 5 / 4 / 0
Upside of the analyst’s targets
+76.1%
Average over 9 current targets, to the last price
The market’s answer to the ratings
+1.7%
Day-0 move against SPY in the rating’s direction, average over 10 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 15on TipRanks 07:55 | GILDQQQSPYGilead Sciences · $195B | Assigned | Hold | $130 → $129−0.8% | −17.4% | +2.2%next day +0.4% | ↗ |
| Oct 12on TipRanks 07:35 | MRKSPYMerck & Company · $358B | Reiterated | Buy | $161 | +10.3% | 0.0%next day −2.4% | ↗ |
| Oct 6on TipRanks Oct 7 05:11 | CRBUIWMCaribou Biosciences · $50M | Downgrade | Hold | $4.00 → $1.00−75.0% | +113.2% | −5.2%next day −45.4% · 5 days −58.5% | ↗ |
| Sep 10on TipRanks Sep 9 06:20 | MRKSPYMerck & Company · $358B | Assigned | Buy | $127 → $161+26.8% | +10.3% | −0.2%next day −1.3% · 5 days −0.1% | ↗ |
| Aug 11on TipRanks 06:20 | IPHAInnate Pharma · $176M | Upgrade | Buy | $3.00 → $4.00+33.3% | +179.7% | −2.8%next day +14.6% · 5 days −3.3% | ↗ |
| Aug 3on TipRanks Aug 4 05:24 | REPLIWMReplimune Group · $1.1B | Upgrade | Buy | $11.00 → $17.00+54.5% | +56.5% | +4.9%next day −1.7% · 5 days +12.7% | ↗ |
| Jul 20on TipRanks Jul 23 21:16 | GILDQQQSPYGilead Sciences · $195B | Downgrade | Hold | $146 → $127−13.0% | −18.7% | −0.6%next day −3.0% · 5 days −1.6% | ↗ |
| May 21on TipRanks 06:15 | CGENCompugen · $202M | Reiterated | Buy | $13.00 → $5.00−61.5% | +155.1% | −3.7%next day +6.9% · 5 days −1.1% | ↗ |
| Apr 20on TipRanks 14:55 | RCUSIWMArcus Biosciences · $2.9B | Reiterated | Buy | $49.00 → $47.00−4.1% | +112.5% | −6.0%next day +8.5% · 5 days +8.8% | ↗ |
| Feb 2on TipRanks 06:10 | BNTXBioNTech SE · $24.1B | Downgrade | Hold | $113 | +28.8% | −4.8%next day +0.3% · 5 days +1.6% | ↗ |
| Nov 17on TipRanks 06:30 | IPSCIWMCentury Therapeutics · $250M | Downgrade | Hold | $7.00 → $2.00−71.4% | +46.0% | +2.6%next day +2.9% · 5 days +7.9% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗